Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07171489 · ClinicalTrials.gov registry record · NA
Efficacy of a Wearable Noninvasive Neuromodulation Device
A NA study, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07171489 is a NA study that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 100 participants.
The verdict
NCT07171489, a NA study, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The aim of this study is to investigate the potential of transcutaneous neuromodulation (TNM) to treat slow colonic transit and constipation, termed the Neurogenic bowel dysfunction (NBD), in people with SCI. In this project, the study team will investigate the impact of an active treatment intervention vs. a sham control intervention on NBD symptoms in patients with SCI. The study hypotheses: * The proposed TNM treatment at a leg point will reduce NBD symptoms between baseline and post-therapy, when compared to the sham-TNM treatment. * The therapeutic effect of TNM to improve the NBD symptoms is associated with improvement of the autonomic function in SCI patients.
Interventions
- DEVICE TNM at a sham-point (AccelBand) - randomized arm
- DEVICE TNM at a leg point (AccelBand)- randomized arm
- DEVICE TNM at a leg point (AccelBand)- open-label
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-07 |
| Est. Completion | 2029-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07171489
The ClinicalTrials.gov registry entry for NCT07171489 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which TNM at a sham-point (AccelBand) - randomized arm is the first listed.
NCT07171489 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07171489 about?
NCT07171489 is a clinical study titled "Efficacy of a Wearable Noninvasive Neuromodulation Device". The aim of this study is to investigate the potential of transcutaneous neuromodulation (TNM) to treat slow colonic transit and constipation, termed the Neurogenic bowel dysfunction (NBD), in people with SCI. In this project, the study team will investigate the impact of an active treatment interven...
What is the current status of trial NCT07171489?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-07. Estimated completion is 2029-11.
What interventions are being tested in trial NCT07171489?
The interventions under investigation include: TNM at a sham-point (AccelBand) - randomized arm (DEVICE), TNM at a leg point (AccelBand)- randomized arm (DEVICE), TNM at a leg point (AccelBand)- open-label (DEVICE).
Who is sponsoring clinical trial NCT07171489?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.